Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 504-510

  Rose, Jeffrey R ^a   Mullarkey, Maureen A ^a   Christ, William J ^a   Hawkins, Lynn D ^a   Lynn, Melvyn ^b   Kishi, Yoshito ^b   Wasan, Kishor M ^c   Peteherych, Kathy ^c   Rossignol, Daniel P ^a,b  

^a EISAI RESEARCH INSTITUTE   (United States)

^b EISAI INC   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

E 5531; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; SEPSIS;

CHOLESTEROL; CHROMATOGRAPHY; HUMANS; LIPID A; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LIPOPROTEINS, HDL; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034001858     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.504-510.2000     Document Type: Article

References (39)

1. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. de Boer, D. M. MacLaren, J. de Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628-2632.
2. Berger, D., S. Schleich, M. Seidelmann, and H. G. Beger. 1991. Demonstration of an interaction between transferrin and lipopolysaccharide - an in vitro study. Eur. Surg. Res. 23:309-316.
3. Billiau, A., and F. Vandekerckhove. 1991. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur. J. Clin. Invest. 21:559-573.
4. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
5. Bone, R. C. 1992. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch. Intern. Med. 152:1381-1389.
6. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457-469.
7. Brown, J. M., M. A. Grosso, and A. H. Harken. 1989. Cytokines, sepsis and the surgeon. Surg. Gynecol. Obstet. 169:568-575.
8. Christ, W. J., O. Asano, A. L. C. Robidoux, M. Perez, Y. A. Wang, G. R. Dubuc, W. E. Gavin, L. D. Hawkins, P. D. Mcguinness, M. A. Mullarkey, M. D. Lewis, Y. Kishi, T. Kawata, J. R. Bristol, J. R. Rose, D. P. Rossignol, S. Kobayashi, L. Hishinuma, A. Kimura, N. Asakawa, K. Katayama, and I. Yamatsu. 1995. E5531, a pure endotoxin antagonist of high potency. Science 268:80-83.
9. Emancipator, K., G. Csako, and R. J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60:596-601.
10. Flegel, W. A., M. W. Baumstark, C. Weinstock, A. Berg, and H. Northoff. 1993. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect. Immun. 61: 5140-5146.
11. Fong, Y., and S. F. Lowry. 1990. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol. Immunopathol. 55:157-170.
12. Hailman, E., J. J. Albers, G. Wolfbauer, A. Y. Tu, and S. D. Wright. 1996. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 271:12172-12178.
13. Harris, H. W., C. Grunfeld, K. R. Feingold, and J. H. Rapp. 1990. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86:696-702.
14. Jin, H. K., R. H. Yang, S. Marsters, A. Ashkenazi, S. Bunting, M. N. Marra, R. W. Scott, and J. B. Baker. 1995. Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. J. Clin. Invest. 95:1947-1952.
15. Kawata, T., J. R. Bristol, D. P. Rossignol, J. R. Rose, S. Kobayashi, H. Yokohama, A. Ishibashi, W. J. Christ, K. Katayama, I. Yamatsu, and Y. Kishi. 1999. E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide. Br. J. Pharmacol. 127:853-862.
16. Kilbourn, R. G., S. S. Gross, A. Jubran, J. Adams, O. W. Griffith, R. Levi, and R. F. Lodato. 1990. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87:3629-3632.
17. Kilbourn, R. G., A. Jubran, S. S. Gross, O. W. Griffith, R. Levi, J. Adams, and R. F. Lodato. 1990. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1132-1138.
18. Lemaire, M., W. M. Pardridge, and G. Chaudhuri. 1988. Influence of blood components on the tissue uptake indices of cyclosporin in rats. J. Pharmacol. Exp. Ther. 244:740-743.
19. Loppnow, H., P. Libby, M. Freudenberg, J. H. Krauss, J. Weckesser, and H. Mayer. 1990. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect. Immun. 58:3743-3750.
20. Oettinger, W., D. Berger, and H. G. Beger. 1987. The clinical significance of prostaglandins and thromboxane as mediators of septic shock. Klin. Wochenschr. 65:61-68.
21. Pajkrt, D., J. E. Doran, F. Koster, P. G. Lerch, B. Arnet, T. van der Poll, J. W. ten Cate, and S. J. van Devenler. 1996. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184:1601-1608.
22. Pardridge, W. M., and L. J. Mietus. 1979. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 64:145-154.
23. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558.
24. Rose, J. R., W. J. Christ, J. R. Bristol, T. Kawata, and D. P. Rossignol. 1995. Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs. Infect. Immun. 63:833-839.
25. Rossignol, D. P., W. J. Christ, L. D. Hawkins, S. Kobayashi, T. Kawata, M. Lynn, I. Yamatsu, and Y. Kishi. 1998. Synthetic endotoxin antagonists. In H. Brade, D. Morrison, S. Opal, and S. Vogel (ed.), Endotoxin in health and disease. Marcel Dekker, Inc., New York, N.Y.
26. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
27. Segrest, J., and J. Albers (ed.). 1986. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol. 128:70-143.
28. Spooner, C. E., N. P. Markowitz, and L. D. Saravolatz. 1992. The role of tumor necrosis factor in sepsis. Clin. Immunol. Immunopathol. 62(1 Pt 2):S11-S17.
29. Takada, K., N. Ohno, and T. Yadomae. 1994. Binding of lysozyme to lipopoiysaccharide suppresses tumor necrosis factor production in vivo. Infect. Immun. 62:1171-1175.
30. Takada, K., N. Ohno, and T. Yadomae. 1994. Lysozyme regulates LPS-induced interleukin-6 release in mice. Circulatory Shock 44:169-174.
31. Vosbeck, K., P. Tobias, H. Mueller, R. A. Allen, K. E. Arfors, R. J. Ulevitch, and L. A. Sklar. 1990. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leukoc. Biol. 47:97-104.
32. Wasan, K. M., G. A. Brazeau, A. Keyhani, A. C. Hayman, and G. Lopez-Berestein. 1993. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrob. Agents Chemother. 37:246-250.
33. Wasan, K. M., P. H. Pritchard, M. Ramaswamy, W. Wong, E. M. Donnachie, and L. J. Brunner. 1997. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine. Pharm. Res. 14:1613-1620.
34. Wasan, K. M., F. W. Strobel, S. C. Parrott, M. Lynn, W. J. Christ, L. D. Hawkins, and D. P. Rossignol. 1999. Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levels. Antimicrob. Agents Chemother. 43:2562-2564.
35. Weinstock, C., H. Ullrich, R. Hohe, A. Berg, M. W. Baumstark, I. Frey, H. Northoff, and W. A. Flegel. 1992. Low density lipoproteins inhibit endotoxin activation of monocytes. Arterioscler. Thromb. 12:341-347.
36. Welbourn, C. R., and Y. Young. 1992. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br. J. Surg. 79:998-1003.
37. Wollenweber, H. W., and D. C. Morrison. 1985. Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative. J. Biol. Chem. 260:15068-15074.
38. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1431-1433.
39. Yu, B., E. Hailman, and S. D. Wright. 1997. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99:315-324.